Concord Healthcare, a subsidiary of Concord Medical Services Holdings Limited, has made significant advancements in tumor diagnosis and treatment with the official release of its Proton Therapy Large Model. This large language model, the first of its kind in China, is specifically designed for proton therapy and has been successfully deployed at the Guangzhou Concord Cancer Hospital. The model leverages over 10,000 high-quality radiotherapy cases and integrates data from Proton China and professional journals to enhance its training. Since its implementation, the proton therapy at Guangzhou Concord Cancer Hospital has demonstrated precise treatment capabilities, significant efficacy, and reduced side effects in patient care. Concord Healthcare's efforts mark a notable progression in the field of precise tumor treatment.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。